Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 3Completed 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 44Pancreatic Neoplasms 17Stomach Neoplasms 16Neoplasm Metastasis 11Rectal Neoplasms 10Neoplasms 10Colonic Neoplasms 7Adenocarcinoma 7Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Esophageal Neoplasms 4Cholangiocarcinoma 4Burkitt Lymphoma 4Advanced Solid Tumors 4Adenocarcinoma Of Esophagus 4Leukemia, Biphenotypic, Acute 3Esophageal Squamous Cell Carcinoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Locally Recurrent Rectal Cancer 2Gallbladder Neoplasms 2Endometrial Neoplasms 2Appendiceal Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1

Interventions

Cisplatin 12pembrolizumab 11Magnetic Resonance Spectroscopy 11Specimen Handling 10Paclitaxel 6Platinum 5Cyclophosphamide 51,2-diaminocyclohexaneplatinum II citrate 5fludarabine 4durvalumab 4cemiplimab 4Radiotherapy, Intensity-Modulated 4Radiotherapy 3Pemetrexed 3Oxaliplatin 3Nivolumab 3Fluorouracil 3Cetuximab 3Carboplatin 3Biopsy 3poly ICLC 2fludarabine phosphate 2cabozantinib 2atezolizumab 2Radiation 2Ipilimumab 2Interviews as Topic 2Heavy Ion Radiotherapy 2Gemcitabine 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma × Leucovorin × Clear all
NCT06941857 2026-05-05

NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Carcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡